academic article

• The future of USP monographs for PET drugs..  Journal of nuclear medicine : official publication, Society of Nuclear Medicine.  54:472-475. 2013
• Alemtuzumab for patients with relapsing multiple sclerosis after disease-modifying therapy: a randomised controlled phase 3 trial..  Lancet.  380:1829-1839. 2012
• Alemtuzumab versus interferon beta 1a as first-line treatment for patients with relapsing-remitting multiple sclerosis: a randomised controlled phase 3 trial..  Lancet.  380:1819-1828. 2012
• Alcohol potently inhibits the kainate receptor-dependent excitatory drive of hippocampal interneurons..  Proceedings of the National Academy of Sciences of the United States of America.  100:6813-6818. 2003